Clemens Gutmann • Cardiovascular Proteomics

Dr. Clemens Gutmann

Education

2011-2017	Medicine (Dr.med.univ.) Innsbruck Medical University, Austria
2013-2017	Molecular Medicine (BSc) Innsbruck Medical University, Austria

Present Appointment

2018-2022

MRes/PhD Student in Cardiovascular Sciences – King’s College London, Funded by a 4-year British Heart Foundation Studentship

MRes(Year 1):
- Pass with Distinction
PhD(Year 2-4):
- Project Title: RNA Biomarkers of Platelet Function
- Supervisors: Prof Manuel Mayr (1st), Dr. Anna Zampetaki (2nd)

Previous Appointments

2017-2018

Medical Foundation Programme (Basisausbildung):

Internal Medicine – LKH Hochzirl, Austria
Cardiology and Angiology – Innsbruck University Hospital, Austria
Cardiac Surgery – Innsbruck University Hospital, Austria

2016-2017

Research Assistant

Angiology Research Lab of Prof Rudolf Kirchmair – Innsbruck Medical University, Austria

2014-2016

Sonography Tutor – Student Project Sono4you – Innsbruck Medical University, Austria

Abdominal Sonography & Echocardiography

Awards & Prizes

2018	British Heart Foundation MRes + PhD Studentship (UK)
2014-2017	Pro Scientia Scholarship (AT)
2017	Scholarship of the Autonomous Province of South Tyrol (IT)

Publications

1	Gutmann C, Stojkovic S, Mayr M. Letter by Gutmann et al Regarding Article, “Circulating MicroRNA-122-5p Is Associated With a Lack of Improvement in Left Ventricular Function After Transcatheter Aortic Valve Replacement and Regulates Viability of Cardiomyocytes Through Extracellular Vesi. *Circulation. 2023 147(4)* : e68–e69. [Full Text] [PubMed] [DOI]
2	Gutmann C, Zelniker TA, Mayr M. SGLT2 inhibitors in heart failure: insights from plasma proteomics. *European Heart Journal*. 2022 : . [Full Text] [PubMed] [DOI]
3	Gutmann C, Mayr M. Circulating microRNAs as biomarkers and mediators of platelet activation. *Platelets. 2022 33(4)* : 512-519. [Full Text] [PubMed] [DOI]
4	Joshi A, Schmidt LE, Burnap SA, Lu R, Chan MV, Armstrong PC, Baig F, Gutmann C, Willeit P, Santer P, Barwari T, Theofilatos K, Kiechl S, Willeit J, Warner T, Mathur A, Mayr M. Neutrophil-Derived Protein S100A8/A9 Alters the Platelet Proteome in Acute Myocardial Infarction and Is Associated With Changes in Platelet Reactivity. *Arteriosclerosis, thrombosis, and vascular biology*. 2021 : ATVBAHA-121. [Full Text] [PubMed] [DOI]
5	Gutmann C, Khamina K, Theofilatos K, Diendorfer AB, Burnap S, Nabeebaccus A, Fish M, McPhail M, Schmidt L, Cassel C, Auzinger G. Association of cardiometabolic microRNAs with COVID-19 severity and mortality. *Cardiovascular Research*. 2021 : . [Full Text] [PubMed] [DOI]
6	Sangiao-Alvarellos S, Theofilatos K, Barwari T, Gutmann C, Takov K, Singh B, Juiz-Valiña P, Varela-Rodríguez BM, Outeiriño-Blanco E, Duregotti E, Zampetaki A, Lunger L, Ebenbichler C, Tilg H, García-Brao MJ, Willeit P, Mena E, Kiechl S, Cordido F, Mayr M. Metabolic recovery after weight loss surgery is reflected in serum microRNAs. *BMJ Open Diabetes Research and Care. 2020 8(2)* : e001441. [Full Text] [PubMed] [DOI]
7	Gutmann C, Takov K, Burnap S, Singh B, Theofilatos K, Reed E, Hasman M, Nabeebaccus A, Fish M, McPhail M, O'Gallagher K, Schmidt L, Cassel C, Rienks M, Yin X, Auzinger G, Napoli S, Mujib S, Trovato F, Sanderson B, Merrick B, Niazi U, Saqi M, Dimitrakopoulou K, Braun S, Kronstein-Wiedemann R, Doores K, Edgeworth J, Shah A, Bornstein S, Tonn T, Hayday A, Shankar-Hari M, Mayr M. SARS-CoV-2 RNAemia and proteomic biomarker trajectory inform prognostication in COVID-19 patients admitted to intensive care. . 2020 : . [Full Text] [DOI]
8	Gutmann C, Joshi A, Mayr M. Platelet "-omics" in health and cardiovascular disease. *Atherosclerosis*. 2020 : . [Full Text] [PubMed] [DOI]
9	Gutmann C, Joshi A, Zampetaki A, Mayr M. The Landscape of Coding and Non-coding RNAs in Platelets. *Antioxidants & Redox Signaling*. 2020 : . [Full Text] [DOI]
10	Braza-Boïls A, Barwari T, Gutmann C, Thomas MR, Judge HM, Joshi A, Pechlaner R, Shankar-Hari M, Ajjan RA, Sabroe I, Storey RF, Mayr M. Circulating MicroRNA Levels Indicate Platelet and Leukocyte Activation in Endotoxemia Despite Platelet P2Y12 Inhibition. *Int J Mol Sci. 2020 21(8)* : 2897. [Full Text] [PubMed] [DOI]